KalVista Pharmaceuticals, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:KALV) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 250.77 M215.5 M339.93 M328.92 M Total liabilities 155.38 M174.72 M322.93 M348.57 M Total equity 95.39 M40.79 M17 M-19.65 M Total liabilities & shareholders' equities 250.77 M215.5 M339.93 M328.92 M Total debt ——139.03 M139.4 M Net debt ——-170.13 M-145.63 M

News

KalVista Scores $1.9 Billion Takeover Deal; Why A Key Rival Jumped Too

KalVista Pharmaceuticals: Ekterly's Launch Momentum Keeps The Bull Case Alive (KALV)

KalVista Pharmaceuticals, Inc. (KALV) 8 Months 2025 Earnings Call Transcript

KalVista Pharmaceuticals Stock Sees RS Rating Jump To 86

KalVista presents sebetralstat data showing early treatment impact

Wall Street Analysts Think KalVista Pharmaceuticals (KALV) Could Surge 117.1%: Read This Before Placing a Bet

International guideline recommends EKTERLY as first-line HAE therapy

KalVista: Next Stage Of Growth For EKTERLY Lies With Pediatric Label Expansion (KALV)

Wall Street Analysts Believe KalVista Pharmaceuticals (KALV) Could Rally 116.4%: Here's is How to Trade

BofA’s Top Four Biotech Stocks to Watch in 2026

Does KalVista Pharmaceuticals (KALV) Have the Potential to Rally 117.98% as Wall Street Analysts Expect?

Kalvista stock surges as Stifel reiterates Buy on strong Ekterly sales